MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
2.760
-0.120 (-4.17%)
Feb 21, 2025, 4:00 PM EST - Market closed
MacroGenics Employees
MacroGenics had 339 employees as of December 31, 2023. The number of employees decreased by 18 or -5.04% compared to the previous year.
Employees
339
Change (1Y)
-18
Growth (1Y)
-5.04%
Revenue / Employee
$416,900
Profits / Employee
-$287,956
Market Cap
173.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MGNX News
- 2 months ago - MacroGenics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 3 months ago - MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - MacroGenics Announces Leadership Transition - GlobeNewsWire
- 4 months ago - MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call - GlobeNewsWire
- 4 months ago - Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders - Accesswire
- 4 months ago - MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA® - Business Wire